Making a Transition Transitioning from a compounded to an FDA-approved GLP-1 medication should be done under the guidance of a health care professional, Alyssa Billingsley, PharmD, director of pharmacy content at GoodRx, said, noting that such an individual can help the patient navigate any changes to the formulation, concentration, dosage, or delivery method
All three of its standard formularies (Premium, Select, and Premium Value) will have the following three products on Tier 2 with prior authorization: Stelara Wezlana for Nuvaila (high list price) Wezlana for Nuvaila (low list price) Express Scripts has stated that its formulary will include Stelara plus a low-list-price private label biosimilar from Quallent
Reports from Q4 2003 to Q1 2024 were analyzed using the OpenVigil 2.1 platform to identify male patients experiencing orgasmic dysfunction, erectile dysfunction, or decreased libido linked to GLP-1 receptor agonists (tirzepatide, semaglutide, dulaglutide, exenatide, lixisenatide, and liraglutide)
But what does it actually mean for your blood sugar, your CGM (continuous glucose monitor) readings, and whether this medication is right for you